Moderate to Severe Asthma: Journal Articles
- Antipsychotics Associated With Severe Asthma Exacerbation Risk
- COVID-19 and Pediatric Asthma: Friend or Foe?
- Cost-Utility of Triple vs Dual Inhaler Therapy in Asthma
- Severe Refractory Asthma Treated With Benralizumab
- Optimizing Inhalation Therapy in COPD and Asthma Patients
- The Effect of Curcumin in Moderate to Severe Asthmatics
- Is Asthma a Risk Factor for COVID-19 Worse Outcomes?
- Spontaneous Resolution of Atopic Dermatitis With Benralizumab
- Asthma, SARS-CoV-2 and COVID-19
- Advances in Allergen Immunotherapy for Asthma
- Asthma Care Quality, Language, and Ethnicity in Children
- Efficacy of Benralizumab for Severe Eosinophilic Asthma
- Serum Prednisolone and Corticosteroid Adherence in Asthma
- Real-Life Experience With Benralizumab During 6 Months
- Mortality Among Adults With Both Asthma and COPD
- Outcomes and Lung Function in Children With Severe Asthma
- Home Visits for Children With Asthma Reduce Medicaid Costs
- Age-Specific Incidence of Allergic and Non-Allergic Asthma
- Indoor Environmental Control Among Children With Asthma
- Asthma/Obstructive Pulmonary Disease Overlap